ÌÇÐÄÆƽâ°æ

Pharmaceutical company Galapagos, headquartered in Belgium but part of the AEX stock exchange in the Netherlands, saw its stock price decrease by over 40 percent between February and March, 2020, and following a mid-year recovery has continued to trend downwards. This was partly caused by concerns over the coronavirus outbreak, as consumer demand could decrease and industries possibly face the effects of a looming recession in 2020. First estimates forecast that the Dutch economy, for example, could see its growth slow down significantly due to the new virus. As of February 3, 2025, the Galapagos stock price was sitting at 22.36 euros, well below its level in early 2020.